Material Transfer Agreement Template for Australia

Generate a bespoke document

Trusted by 200k+ teams

4.7 Capterra
4.8 Product Hunt
4.6 Trustpilot

What is a Material Transfer Agreement?

Material Transfer Agreements (MTAs) are essential legal instruments in Australia used when tangible materials need to be transferred between organizations for research, development, or evaluation purposes. These agreements are particularly crucial in scientific, medical, and biotechnology contexts where materials such as cell lines, plasmids, chemicals, or other biological materials are shared. The document ensures compliance with Australian regulatory requirements, including biosecurity regulations, gene technology laws, and intellectual property protection. It establishes clear terms for material usage, defines ownership rights, sets confidentiality obligations, and allocates risks between parties. MTAs are fundamental in protecting both the provider's and recipient's interests while promoting scientific collaboration and innovation within the bounds of Australian law.

Reviewed by

Swetha Meenal

Legal Engineer, GenieAI

Swetha Meenal profile photo

A lawyer, legal researcher and legal tech founder, Swetha has built AI products deployed inside Tier 1 firms and enterprises. She ensures GenieAI's alignment with the latest regulation and executes testing on the legal robustness of Genie output.

Reviewed by

Imad Mohammed Nazar

Legal Engineer, GenieAI

Imad Mohammed Nazar profile photo

A Skadden-trained M&A lawyer, Imad advised on cross-border transactions and contractual risk before moving into legal AI. He reviews GenieAI's output for compliance and enforceability across our 150+ supported jurisdictions, as well as facilitating external benchmarking.

Jurisdiction

Australia

Publisher

GenieAI

Sector

Business

Cost

Free to use

Last updated

About the Material Transfer Agreement

When your organization needs to transfer or receive research materials in Australia, a Material Transfer Agreement (MTA) provides the essential legal framework to protect all parties involved. This specialized contract governs the sharing of tangible materials such as biological specimens, cell lines, chemical compounds, or research tools between institutions while ensuring compliance with Australian regulatory requirements.

When do you need this document?

You need an MTA whenever your organization transfers physical materials for research purposes. Universities sharing cell lines with biotech companies require MTAs to protect their intellectual property and establish usage restrictions. Pharmaceutical companies collaborating on drug development need these agreements when exchanging chemical compounds or biological samples. Government research agencies must use MTAs when providing materials to commercial laboratories, ensuring proper handling and preventing unauthorized use. Medical institutions sharing patient-derived samples require MTAs that comply with privacy regulations and ethical requirements. Agricultural research centers transferring plant materials or genetic resources need agreements that address biosecurity concerns and environmental protection.

Key legal considerations

Your MTA must clearly define the scope of permitted use, ensuring materials are only used for specified research purposes and preventing unauthorized commercialization. Intellectual property clauses should address ownership of the original materials, any derivatives created, and future discoveries or inventions arising from their use. Confidentiality provisions protect proprietary information shared alongside the materials, while publication restrictions may apply to research results. Liability and indemnification clauses allocate risks between parties, particularly important when dealing with potentially hazardous biological materials. The agreement should specify return or destruction requirements for unused materials and establish procedures for handling any resulting intellectual property or commercial applications.

Legal requirements in Australia

Your MTA must comply with the Biosecurity Act 2015 if materials cross international borders or involve organisms that could pose biosecurity risks. This includes obtaining necessary import or export permits and following quarantine procedures. The Gene Technology Act 2000 applies when transferring genetically modified organisms, requiring compliance with regulatory oversight and licensing requirements. If materials involve human biological samples, the Privacy Act 1988 mandates protection of personal information and may require de-identification procedures. The Patents Act 1990 governs intellectual property rights associated with transferred materials, affecting how you can use and develop derivatives. Environmental protection laws under the Environment Protection and Biodiversity Conservation Act 1999 may apply to transfers involving protected species or materials that could impact biodiversity. Your agreement should include specific clauses addressing these regulatory requirements and assign responsibility for obtaining necessary approvals or permits.

Genie's Security Promise

Genie is the safest place to draft. Here's how we prioritise your privacy and security.

Your data is private:

We do not train on your data; Genie's AI improves independently

All data stored on Genie is private to your organisation

Your documents are protected:

Your documents are protected by ultra-secure 256-bit encryption

We are ISO27001 certified, so your data is secure

Organizational security:

You retain IP ownership of your documents and their information

You have full control over your data and who gets to see it